The inflammatory response of keratinocytes and its modulation by vitamin D: The role of MAPK signaling pathways

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 2175-2183

  Miodovnik, Mor ^a   Koren, Ruth ^a   Ziv, Esther ^a   Ravid, Amiram ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CYTOCHROME P 450 27B1; CYTOCHROME P450; DOUBLE STRANDED RNA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OXYGENASE; POLYINOSINIC POLYCYTIDYLIC ACID; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CELL LINE; ENZYME INHIBITORS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON INDUCERS; INTERLEUKIN-8; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MICROARRAY ANALYSIS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLY I-C; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMINS;

EID: 84856174778     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22951     Document Type: Article

References (38)

1. Albanesi C, De Pità O, Girolomoni G. 2007. Resident skin cells in psoriasis: A special look at the pathogenetic functions of keratinocytes. Clin Dermatol 25: 581-588.
2. Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G. 2005. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 4: 329-334.
3. An L, Dong GQ, Gao Q, Zhang Y, Hu LW, Li JH, Liu Y. 2010. Effects of UVA on TNF-alpha, IL-1beta, and IL-10 expression levels in human keratinocytes and intervention studies with an antioxidant and a JNK inhibitor. Photodermatol Photoimmunol Photomed 26: 28-35.
4. Bahar-Shany K, Ravid A, Koren R. 2010. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D. J Cell Physiol 222: 729-737.
5. Bikle DD. 2004. Vitamin D regulated keratinocyte differentiation. J Cell Biochem 92: 436-444.
6. Bikle DD. 2005. Vitamin D: Role in skin and hair. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D, 2nd edn. Boston, San Diego, London: Elsevier Academic Press. pp 609-630.
7. Birlea SA, Costin GE, Norris DA. 2008. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets 9: 345-359.
8. Cheung PC, Campbell DG, Nebreda AR, Cohen P. 2003. Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. EMBO J 22: 5793-5805.
9. Cohen M, Meisser A, Haenggeli L, Bischof P. 2006. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod 12: 225-232.
10. Dai X, Sayama K, Tohyama M, Shirakata Y, Yang L, Hirakawa S, Tokumaru S, Hashimoto K. 2008. The NF-kappaB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes. Int Immunol 20: 901-909.
11. Diker-Cohen T, Koren R, Ravid A. 2006. Programmed cell death of stressed keratinocytes and its inhibition by vitamin D: The role of death and survival signaling pathways. Apoptosis 11: 519-534.
12. Garach-Jehoshua O, Ravid A, Liberman UA, Koren R. 1999. 1, 25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes. Endocrinology 140: 713-721.
13. Gurlek A, Pittelkow MR, Kumar R. 2002. Modulation of growth factor/cytokine synthesis and signaling by 1alpha, 25-dihydroxyvitamin D(3): Implications in cell growth and differentiation. Endocr Rev 23: 763-786.
14. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. 2002. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855.
15. Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen M, Binderup L, Skak-Nielsen T, Fjording MS, Iversen L., 2006. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol 176: 1431-1438.
16. Kassardjian A, Kreydiyyeh SI. 2008. JNK modulates the effect of caspases and NF-kappaB in the TNF-alpha-induced down-regulation of Na+/K+ATPase in HepG2cells. Cell Physiol 216: 615-620.
17. Kyryakis JM, Avruch J. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869.
18. Lehmann B, Querings K, Reichrath J. 2004. Vitamin D and skin: New aspects for dermatology. Exp Dermatol 13: 11-15.
19. Lewis DA, Spandau DF. 2008. UVB-induced activation of NF-kappaB is regulated by the IGF-1R and dependent on p38 MAPK. J Invest Dermatol 128: 1022-1029.
20. Liu SF, Malik AB. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290: L622-L645.
21. Ravid A, Rubinstein E, Gamady A, Liberman UA, Rotem C, Koren R. 2002. Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol 173: 525-532.
22. Reichrath J. 2007. Vitamin D and the skin: An ancient friend, revisited. Exp Dermatol 16: 618-625.
23. Reimhold AM. 2002. TNF alpha as therapeutic target: New drugs, more appliocations. Curr Drug Targets Inflamm Allergy 1: 377-392.
24. Riis JL, Johansen C, Gesser B, Møller K, Larsen CG, Kragballe K, Iversen L. 2004. 1alpha, 25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression. Arch Dermatol Res 296: 195-202.
25. Schauber J, Gallo RL. 2008. The vitamin D pathway: A new target for control of the skin's immune response? Exp Dermatol 17: 633-639.
26. Schauber J, Dorschner RA, Cuda AB. 2007. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117: 803-811.
27. Schieven GL. 2005. The biology of p38 kinase: A central role in inflammation. Curr Top Med Chem 5: 921-928.
28. Singer CA, Baker KJ, McCaffrey A, AuCoin DP, Dechert MA, Gerthoffer WT. 2003. p38 MAPK and NF-kappaB mediate COX-2 expression in human airway myocytes. Am J Physiol Lung Cell Mol Physiol 285: L1087-L1098.
29. Son SW, Min BW, Lim Y, Lee YH, Shin SY. 2008. Regulatory mechanism of TNF alpha autoregulation in HaCaT cells: The role of the transcription factor EGR-1. Biochem Biophys Res Commun 374: 777-782.
30. Spellberg B. 2000. The cutaneous citadel: A holistic view of skin and immunity. Life Sci 67: 477-502.
31. Steinhoff M, Brazoska T, Luger TA. 2001. Keratinocytes in epidermal immune responses. Curr Opin Allergy Clin Immunol 1: 469-476.
32. Thalhamer T, McGrath MA, Harnett MM. 2008. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 47: 409-414.
33. Yu XP, Bellido T, Manolagas SC. 1995. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1, 25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 92: 10990-10994.
34. Vercammen E, Staal J, Beyaert R. 2008. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 21: 13-25.
35. Wagner EF, Nebreda AR. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
36. Zhao J, Benakanakere MR, Hosur KB, Galicia JC, Martin M, Kinane DF. 2010. Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes. Mol Immunol 48: 294-304.
37. Zasloff M. 2005. Sunlight, vitamin D, and the innate immune defenses of the human skin. J Invest Dermatol 125: xvi-xvii.
38. Ziv E, Rotem C, Miodovnik M, Ravid A, Koren R. 2008. Two modes of ERK activation by TNF in keratinocytes: Different cellular outcomes and bi-directional modulation by vitamin D. J Cell Biochem 104: 606-619.